FDA Approves Vanda's NEREUS For Motion Sickness; Shares Jump Over 20% In Overnight Trading
(RTTNews) - Vanda Pharmaceuticals Inc. (VNDA) announced that the U.S. Food and Drug Administration (FDA) has approved NEREUS (tradipitant), an ora...
31 Dec 02:11 · finanzen.at